Results from a study published in the American Journal of Infection Control showed ventilator-associated pneumonia was the most frequent adverse event related to deaths in the ICU at a university ...

Since 2007, we have set as a priority in our hospital the eradication of nosocomial infections. To this end, we have developed a set of best practices for prevention of ventilator associated pneumonia ...

Research published in JAMA shows ventilator-associated pneumonia rates have stayed steady since 2005, contradicting CDC data showing a decline in VAP rates. “VAP is not going away; it still affects ...

Antibiotic overuse is a key driver in the rise of antimicrobial resistance (AMR), a major global health crisis. Researchers from the Yong Loo Lin School of Medicine, National University of Singapore ...

In the realm of critical care, the contributions of dental professionals are often overlooked, yet they play a pivotal role in patient recovery. As we celebrate Dentist Day on Saturday, the 25th, the ...

Endotracheal tubes (ETTs) are indispensable in the management of critically ill patients requiring mechanical ventilation. However, their use is invariably linked with ventilator-associated pneumonia ...

In a randomized trial involving critically ill patients who had undergone mechanical ventilation for 3 days, a 3-day course of inhaled amikacin reduced the burden of ventilator-associated pneumonia.

Countless families have seen their loved ones pass away due to pneumonia. Why is this such a deadly diagnosis?

New data presented at IDWeek 2025 by Japanese drugmaker Shionogi highlight the real-world effectiveness of cefiderocol in ...

The European Medicines Agency (EMA) has recommended that the medicinal product cefepime-enmetazobactam (Exblifep) should be granted a marketing authorization for treating adults with urinary tract ...